Nephroprotective effects of L-carnitine against contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a randomized open-labeled clinical trial
Journal of Tehran University Heart Center [The]. 2017; 12 (2): 57-64
en Inglés
| IMEMR
| ID: emr-190812
ABSTRACT
Background:
L-carnitine may prevent the incidence of AKI by its antioxidant effects and improving circulation in ischemic conditions. The goal of this trial was to evaluate the impact of L-carnitine on contrast-induced nephropathy in patients undergoing elective PCI
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Inglés
Revista:
J. Tehran Univ. Heart Cent.
Año:
2017
Similares
MEDLINE
...
LILACS
LIS